Influential Women spotlights scientist and educator Kavitha Govindasamy

Influential Women is highlighting Kavitha Govindasamy, PhD, a Jersey City-based scientist and academic leader whose work spans parasite biology, vaccine research, and healthcare education. Her career connects lab research at institutions including Rutgers and Harvard with efforts to expand STEM access for diverse learners.

Why it matters: - Kavitha Govindasamy’s career links biomedical research with teaching and academic leadership. - Her work has centered on infectious disease, vaccine development, and education for students entering healthcare and STEM fields. - Her profile also reflects a broader push to expand opportunity for women, adult learners, and underrepresented communities in science.

What happened: - Influential Women published a profile on Kavitha Govindasamy, PhD, on Aug. 13, 2026. - Govindasamy is based in Jersey City, New Jersey. - She holds a PhD in Molecular Entomology from the Indian Agricultural Research Institute. - She currently serves as an Instructor at Harvard University and Dean of Academic Affairs at Eastern International College. - Her academic background includes faculty roles at Princeton University, Rutgers University–Newark, New Jersey Medical School, the University of Medicine and Dentistry of New Jersey, Kean University, Montclair State University, Rowan University, Seton Hall University, Stockton University, Felician University and William Paterson University of New Jersey.

The details: - Govindasamy began her career in infectious disease research before moving into academia. - Her research has covered molecular parasitology, vector-borne diseases, host–pathogen interactions, molecular genetics, microbiology, immunology, cancer biology, and drug and vaccine discovery. - She has studied malaria parasites, Babesia microti, and human cytomegalovirus. - Her Babesia microti work established a stable transfection and genetic manipulation system and identified a bidirectional promoter that regulates genes on both sides of the promoter. - That research was published in Nature Scientific Reports in 2020. - The system enabled stable expression of foreign markers such as GFP and mCherry. - The Babesia work supported reverse-genetic studies and efforts to identify therapeutic and vaccine targets. - Her malaria research examined pre-erythrocytic and liver-stage Plasmodium biology. - Her publications include findings on cGMP-dependent protein kinase and calcium-dependent protein kinase 4 in hepatocyte invasion by Plasmodium sporozoites. - Her technical experience includes CRISPR-Cas methods, gene tagging, site-directed mutagenesis, protein localization, molecular cloning, sequencing, PCR, Western blotting, flow cytometry, microscopy, and in vivo and ex vivo parasite studies. - She helped develop a chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development using centanamycin. - The approach chemically modifies DNA-virus genomes to block replication while preserving viral particles that can trigger an immune response. - The methodology was shown to work on human cytomegalovirus, mouse cytomegalovirus, and herpes simplex virus-2. - Mice immunized with centanamycin-attenuated mouse cytomegalovirus produced a robust immune response and had lower viral loads after challenge with live wild-type virus. - The work was published in Cell Reports Methods in 2022 as "A chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development." - Rutgers University News highlighted the research under the headline "Rutgers Scientists Produce ‘DNA Virus Vaccine’ to Fight DNA Viruses." - Her research portfolio also includes chemically attenuated vaccine strategies for Borrelia burgdorferi, the bacterium that causes Lyme disease. - She has studied human cytomegalovirus in cancer, including mechanisms tied to HCMV-induced carcinogenesis, with that work published in Frontiers in Cellular and Infection Microbiology in 2023. - Her publications also appear in journals including PLOS Pathogens, Molecular Microbiology, Infection and Immunity, ACS Chemical Biology, and Proceedings of the National Academy of Sciences. - Her current teaching portfolio includes biomedical sciences, immunology, R programming, bioinformatics, statistics, molecular biology, cell biology, biochemistry, microbiology, infectious disease, anatomy and physiology, pathophysiology, evolutionary genetics, ecology and biodiversity, life sciences, advanced genetics, genomics, epigenetics, evolutionary medicine and molecular virology.

Between the lines: - Govindasamy’s work shows a translational approach that moves from basic molecular biology toward therapies, vaccines, and diagnostics. - Her career also illustrates how research expertise can translate into curriculum leadership and student mentorship. - Her emphasis on mentorship and educational equity suggests a focus on widening the pipeline into healthcare and science. - She has also pointed to persistent gender- and race-based barriers in funding, recognition, and advancement in science and academia.

What's next: - Govindasamy continues to combine teaching, academic leadership, and mentorship with research-driven advocacy for STEM access. - Her profile points to ongoing work supporting adult learners, women, and underrepresented students pursuing healthcare careers. - More information is available through her Influential Women profile.

The bottom line: - Kavitha Govindasamy’s career spans the lab, the classroom, and student mentorship, with a consistent focus on turning scientific knowledge into practical health and education impact.